Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2023 13:00 ET | Source: SPHERICAL INSIGHTS LLP

Global Bioidentical Hormones Market Size To Grow USD 10.10 Billion By 2030 | CAGR 6.50%

New York, United States , March 09, 2023 (GLOBE NEWSWIRE) -- The Global Bioidentical Hormones Market Size to grow from USD 6.20 billion in 2021 to USD 10.10 billion by 2030, at a Compound Annual...
February 01, 2022 09:42 ET | Source: PAO Group, Inc.

PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development

Sandusky, OH, Feb. 01, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development...
November 24, 2021 09:15 ET | Source: PAO Group, Inc.

PAOG Acquisition To Expand CBD IP Portfolio Scheduled To Close December 3rd

Sandusky, OH, Nov. 24, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the acquisition of an exclusive license to patented cannabis extraction process that will expand the...
November 19, 2021 09:00 ET | Source: PAO Group, Inc.

PAOG Announces Pending Acquisition To Expand CBD IP Portfolio Scheduled For Early December

Sandusky, OH, Nov. 19, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized terms for the acquisition of a license to a patented cannabis extraction...
November 17, 2021 10:10 ET | Source: PAO Group, Inc.

PAOG New Pharmaceutical Product Developments Could Generate Rapid Revenue Surge

Sandusky, OH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC PINK: PAOG) today confirmed plans to add multiple new pharmaceutical products to its development pipeline in addition to its...
November 09, 2021 13:03 ET | Source: PAO Group, Inc.

PAOG Expects To Soon Launch 3rd CBD Nutraceutical Adding To 2021 Revenue Potential

Sandusky, OH, Nov. 09, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is on track to introduce yet a third CBD nutraceutical product by year end. PAOG...
November 08, 2021 11:42 ET | Source: PAO Group, Inc.

PAOG Adds Bioidentical Synthetic CBD To Research Pipeline

Sandusky, OH, Nov. 08, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company adding bioidentical synthetic CBD to its overall research initiative. PAOG...